Looking Ahead to Regulation in 2016
Although Congress will not likely enact new legislation in President Obama’s final year in office, regulatory agencies are a different matter.
Commentaries & Insights
Our Commentaries and Insights are short-form publications intended to distill long-form research and synthesize current policymaking activity into easily understood concepts.
President Obama’s Regulatory Output: Looking Back at 2015 and Ahead to 2016
HHS leads the way in finalizing new economically significant rules
Are Chemical Risk Assessment and Benefit-Cost Analysis Compatible?
Executive Order 12866 requires benefit-cost analyses for all regulations; in many cases these economic analyses rely upon risk assessment for critical inputs. Usually this is not a problem; in principle, risk assessment and benefit-cost analysis are perfectly compatible.
Herding Genetically Engineered Animals to Market
FDA’s decision to approve a genetically engineered salmon for human consumption bodes well for people interested in cheaper fish.
Missed Opportunity for EPA to Cut Back Renewable Fuel Standard
Congress and EPA should reevaluate whether the Renewable Fuel Standard is accomplishing its goals.
Midnight Rules: A Comparison of Regulatory Output Across Administrations
Understanding Midnight Regulatory Activity and how it's used
The public policy world is not exempt misunderstandings, and the renewed emphasis on retrospective regulatory review is a case in point.
Political Discourse Includes Regulatory Reform
This commentary provides a brief review of what the 2016 presidential candidates have to say about regulatory reform.
Early Notice from U.S. Agencies Could Help Avoid Creating Barriers to Trade
Early Notice from U.S. Agencies Could Help Avoid Creating Barriers to Trade